A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas

NCT01051635 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

55

Enrollment

NIH

Sponsor class

Conditions

Neoplasms
Lymphoma

Interventions

DRUG: LMP400
DRUG: LMP776

Sponsor

National Cancer Institute (NCI)